Information Provided By:
Fly News Breaks for March 26, 2019
CME
Mar 26, 2019 | 06:19 EDT
Barclays analyst Jeremy Campbell lowered his price target for CME Group to $193 from $210 to reflect a "challenged" near-term environment but says his longer-term bullish thesis remains intact. The analyst sees "tough sledding" in the near-term for CME as interest rate derivative trading drives ~25% of its revenue. Rates volume activity is currently weak due to the broad consensus view that rates are going nowhere and the Fed's no rate hike outlook into 2020 has weighed on CME shares, Campbell tells investors in a research note. He believes estimates for CME need to come down but keeps an Overweight rating on the name.
News For CME From the Last 2 Days
There are no results for your query CME